| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen
|
Jain, Shilpa L.
|
|
1996
|
14 |
13 |
p. 1291-1297
7 p.
|
article
|
| 2 |
Annual influenza vaccination: immune response in patients over 10 years
|
Gross, Peter A.
|
|
1996
|
14 |
13 |
p. 1280-1284
5 p.
|
article
|
| 3 |
An outbreak of vaccination panic
|
D'Argenio, Paolo
|
|
1996
|
14 |
13 |
p. 1289-1290
2 p.
|
article
|
| 4 |
Aqueous-based microencapsulation enhances virus-specific humoral immune responses in mice after parenteral inoculation
|
Moser, Charlotte A.
|
|
1996
|
14 |
13 |
p. 1235-1238
4 p.
|
article
|
| 5 |
Association of placental transfer of anti-Haemophilus influenzae type b polysaccharide antibodies with their V regions
|
Park, M.K.
|
|
1996
|
14 |
13 |
p. 1219-1222
4 p.
|
article
|
| 6 |
Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations—III
|
Aggerbeck, Henrik
|
|
1996
|
14 |
13 |
p. 1265-1272
8 p.
|
article
|
| 7 |
Calendar
|
|
|
1996
|
14 |
13 |
p. 1300-
1 p.
|
article
|
| 8 |
DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2
|
Bourne, Nigel
|
|
1996
|
14 |
13 |
p. 1230-1234
5 p.
|
article
|
| 9 |
Erratum
|
|
|
1996
|
14 |
13 |
p. 1298-
1 p.
|
article
|
| 10 |
Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine
|
Tarr, Philip E.
|
|
1996
|
14 |
13 |
p. 1199-1204
6 p.
|
article
|
| 11 |
Human adenovirus type 5 vectors expressing rabies glycoprotein
|
Yarosh, Oksana K.
|
|
1996
|
14 |
13 |
p. 1257-1264
8 p.
|
article
|
| 12 |
International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants
|
Barnett, P.V.
|
|
1996
|
14 |
13 |
p. 1187-1198
12 p.
|
article
|
| 13 |
International meeting on the nucleic acid vaccines for the prevention of infectious disease and regulating nucleic acid (DNA) vaccines
|
Spier, R.E.
|
|
1996
|
14 |
13 |
p. 1285-1288
4 p.
|
article
|
| 14 |
Modification of T-lymphocyte responsiveness without eliciting a superantigen-mediated response using Staphylococcus aureus TSST-1 superantigen derivative; useful for preventing and treating antigen-mediated diseases, such as toxic shock syndrome
|
|
|
1996
|
14 |
13 |
p. 1299-
1 p.
|
article
|
| 15 |
Modulation of the immune response; recombinant antigen preparation by CD21 ligand, CD19 ligand or C3d fusion protein gene expression in host cell; application in improved recombinant vaccine
|
|
|
1996
|
14 |
13 |
p. 1299-
1 p.
|
article
|
| 16 |
Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine
|
|
|
1996
|
14 |
13 |
p. 1299-
1 p.
|
article
|
| 17 |
Mutant viruses for vaccine production; herpes simplex virus-1 or -2 or adenovirus attenuation by deletion or antisense RNA expression for use as recombinant vaccine vector
|
|
|
1996
|
14 |
13 |
p. 1299-
1 p.
|
article
|
| 18 |
Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro
|
Xing, Dorothy K.-L.
|
|
1996
|
14 |
13 |
p. 1205-1213
9 p.
|
article
|
| 19 |
Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy
|
Kurikka, Sari
|
|
1996
|
14 |
13 |
p. 1239-1242
4 p.
|
article
|
| 20 |
Production of a genetically engineered inhibin vaccine
|
Geary, T.W.
|
|
1996
|
14 |
13 |
p. 1273-1279
7 p.
|
article
|
| 21 |
Prospects for the use of new vaccines in developing countries: cost is not the only impediment
|
Hausdorff, William P.
|
|
1996
|
14 |
13 |
p. 1179-1186
8 p.
|
article
|
| 22 |
Recombinant virus for enhancing immune response; recombinant vaccinia virus construction, for application as a recombinant vaccine, for cancer and microorganism and virus infection therapy
|
|
|
1996
|
14 |
13 |
p. 1299-
1 p.
|
article
|
| 23 |
Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60
|
Falsey, Ann R.
|
|
1996
|
14 |
13 |
p. 1214-1218
5 p.
|
article
|
| 24 |
Size effect on the antibody production induced by biodegradable microspheres containing antigen
|
Nakaoka, Ryusuke
|
|
1996
|
14 |
13 |
p. 1251-1256
6 p.
|
article
|
| 25 |
Vaccination protects β 2 microglobulin deficient mice from immune mediated mortality but not from persisting viral infection
|
Hildeman, David
|
|
1996
|
14 |
13 |
p. 1223-1229
7 p.
|
article
|
| 26 |
Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response
|
Bishop, Sarah A.
|
|
1996
|
14 |
13 |
p. 1243-1250
8 p.
|
article
|
Journal description